Label: DISCOUNT DRUG MART MAXIMUM STRENGTH URINARY PAIN RELIEF- phenazopyridine hydrochloride tablet
-
Contains inactivated NDC Code(s)
NDC Code(s): 10956-552-12 - Packager: Reese Pharmaceutical Co
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
- Marketing Status: unapproved drug other
DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.
Drug Label Information
Updated January 30, 2019
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Active ingredient (in each tablet)
- Purpose
- Warnings
- Ask doctor before use if you have
- When using this product
- Stop use and ask doctor if
- If pregnant or breast feeding,
- Keep out of reach of children
- Use
- Inactive ingredients
- Directions
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
DISCOUNT DRUG MART MAXIMUM STRENGTH URINARY PAIN RELIEF
phenazopyridine hydrochloride tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:10956-552 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength PHENAZOPYRIDINE HYDROCHLORIDE (UNII: 0EWG668W17) (PHENAZOPYRIDINE - UNII:K2J09EMJ52) PHENAZOPYRIDINE HYDROCHLORIDE 97.5 mg Inactive Ingredients Ingredient Name Strength LACTOSE (UNII: J2B2A4N98G) MAGNESIUM SILICATE (UNII: 9B9691B2N9) Product Characteristics Color red Score no score Shape ROUND Size 7mm Flavor Imprint Code 975 Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:10956-552-12 1 in 1 CARTON 01/04/2010 1 12 in 1 BLISTER PACK; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 01/04/2010 Labeler - Reese Pharmaceutical Co (004172052) Registrant - Reese Pharmaceutical Co (004172052) Establishment Name Address ID/FEI Business Operations Reese Pharmaceutical Co 004172052 relabel(10956-552) , repack(10956-552)